Toth Financial Advisory’s 20/20 Biolabs Inc AIDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AIDX
Toth Financial Advisory's AIDX Position: Q2 2026 in Review
Toth Financial Advisory reduced its 20/20 Biolabs Inc (AIDX) stake by 36% in Q2 2026, selling an estimated $72 and leaving 100 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #873.
Toth Financial Advisory first reported a position in AIDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $296 in Q1 2026. 3 funds tracked by Wall St. Rank hold AIDX as of Q2 2026.
- Toth Financial Advisory held 100 shares of 20/20 Biolabs Inc worth $55 as of Q2 2026.
- Toth Financial Advisory sold 57 20/20 Biolabs Inc shares in Q2 2026, an estimated $72.
- 20/20 Biolabs Inc made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #873 holding.
- Toth Financial Advisory first reported a position in 20/20 Biolabs Inc in Q1 2026 and has held it in 2 quarters since.
- Toth Financial Advisory's 20/20 Biolabs Inc position peaked at $296 in Q1 2026.
- 3 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q2 2026.
Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.